• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Enhancing therapeutic decision making when options abound: toxicities matter.

作者信息

Kuderer Nicole M, Wolff Antonio C

机构信息

University of Washington School of Medicine, Seattle, WA

Johns Hopkins Kimmel Cancer Center, Baltimore, MD.

出版信息

J Clin Oncol. 2014 Jul 1;32(19):1990-3. doi: 10.1200/JCO.2014.55.1903. Epub 2014 May 27.

DOI:10.1200/JCO.2014.55.1903
PMID:24868027
Abstract
摘要

相似文献

1
Enhancing therapeutic decision making when options abound: toxicities matter.当选择众多时增强治疗决策：毒性很重要。
J Clin Oncol. 2014 Jul 1;32(19):1990-3. doi: 10.1200/JCO.2014.55.1903. Epub 2014 May 27.
2
Risk of hospitalization according to chemotherapy regimen in early-stage breast cancer.早期乳腺癌患者的化疗方案与住院风险。
J Clin Oncol. 2014 Jul 1;32(19):2010-7. doi: 10.1200/JCO.2013.49.3676. Epub 2014 May 27.
3
[Importance of the composition of various combination regimens in the chemotherapy of metastatic breast cancer].[不同联合方案组成在转移性乳腺癌化疗中的重要性]
Dtsch Med Wochenschr. 1987 Feb 13;112(7):270-5. doi: 10.1055/s-2008-1068044.
4
Paclitaxel and doxorubicin in metastatic breast cancer.紫杉醇与阿霉素用于转移性乳腺癌治疗
J Clin Oncol. 1996 Apr;14(4):1403.
5
[Adjuvant chemotherapy of breast cancer: persistent controversy].[乳腺癌辅助化疗：持续的争议]
Klin Wochenschr. 1984 Feb 15;62(4):145-8. doi: 10.1007/BF01731636.
6
Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy.骨骼肌测量作为接受紫杉烷类化疗的转移性乳腺癌患者毒性、住院和生存的预测指标
Clin Cancer Res. 2017 Feb 1;23(3):658-665. doi: 10.1158/1078-0432.CCR-16-0940. Epub 2016 Aug 3.
7
When not to treat--chemotherapy for small (< or = 1 cm) breast cancers.何时不进行治疗——小（≤1厘米）乳腺癌的化疗
Breast Dis. 2004;21:33-40. doi: 10.3233/bd-2004-21105.
8
[Chemotherapy and immunotherapy of metastasized breast carcinoma].[转移性乳腺癌的化疗与免疫治疗]
Internist (Berl). 2002 Mar;43(3):354-63. doi: 10.1007/s00108-001-0524-2.
9
Management of Patients With Febrile Neutropenia: A Teachable Moment.发热性中性粒细胞减少症患者的管理：一个可用于教学的时机。
JAMA Intern Med. 2018 Apr 1;178(4):558-559. doi: 10.1001/jamainternmed.2017.8386.
10
Utility of molecular tools for extended adjuvant endocrine therapy decisions in early breast cancer.分子工具在早期乳腺癌延长辅助内分泌治疗决策中的应用
Future Oncol. 2017 Dec;13(30):2733-2736. doi: 10.2217/fon-2017-0427. Epub 2017 Nov 23.

引用本文的文献

1
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer.大流行阶段调整的 COVID-19 结局分析显示，乳腺癌患者的严重急性呼吸综合征冠状病毒 2 内在易感性降低和疫苗保护作用显著。
J Clin Oncol. 2023 May 20;41(15):2800-2814. doi: 10.1200/JCO.22.01667. Epub 2023 Jan 31.
2
Mitigating acute chemotherapy-associated adverse events in patients with cancer.减轻癌症患者化疗相关急性不良事件。
Nat Rev Clin Oncol. 2022 Nov;19(11):681-697. doi: 10.1038/s41571-022-00685-3. Epub 2022 Oct 11.
3
Incidence and clinical course of septic shock in neutropenic patients during chemotherapy for gynecological cancers.
中性粒细胞减少症患者妇科癌症化疗期间脓毒性休克的发生率和临床病程。
J Gynecol Oncol. 2020 Sep;31(5):e62. doi: 10.3802/jgo.2020.31.e62.
4
Do current approaches to assessing therapy related adverse events align with the needs of long-term cancer patients and survivors?当前评估治疗相关不良事件的方法是否符合长期癌症患者及幸存者的需求？
Cardiooncology. 2018 Jun 15;4:5. doi: 10.1186/s40959-018-0031-4. eCollection 2018.
5
Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and research.将儿童和青少年自我报告的症状数据与临床医生报告的不良事件分级进行映射，以改善儿科肿瘤学的护理和研究。
Cancer. 2020 Jan 1;126(1):140-147. doi: 10.1002/cncr.32525. Epub 2019 Sep 25.
6
Usability of an online application for reporting the burden of side effects in cancer patients.在线应用程序报告癌症患者副作用负担的可用性。
Support Care Cancer. 2019 Sep;27(9):3411-3419. doi: 10.1007/s00520-019-4639-1. Epub 2019 Jan 17.
7
Efficacy, safety and proper dose analysis of PEGylated granulocyte colony-stimulating factor as support for dose-dense adjuvant chemotherapy in node positive Chinese breast cancer patients.聚乙二醇化粒细胞集落刺激因子在支持中国淋巴结阳性乳腺癌患者进行剂量密集辅助化疗中的疗效、安全性及合适剂量分析
Oncotarget. 2017 May 24;8(45):80020-80028. doi: 10.18632/oncotarget.18145. eCollection 2017 Oct 3.
8
Incidence of Neutropenia in Veterans Receiving Lung Cancer Chemotherapy: A Comparison of Administrative Coding and Electronic Laboratory Data.接受肺癌化疗的退伍军人中性粒细胞减少症的发病率：行政编码与电子实验室数据的比较
EGEMS (Wash DC). 2017 Mar 13;5(1):1269. doi: 10.13063/2327-9214.1269. eCollection 2017.
9
The use of and adherence to CTCAE v3.0 in cancer clinical trial publications.癌症临床试验出版物中CTCAE v3.0的使用与遵循情况。
Oncotarget. 2016 Oct 4;7(40):65577-65588. doi: 10.18632/oncotarget.11576.
10
Use and misuse of common terminology criteria for adverse events in cancer clinical trials.癌症临床试验中不良事件通用术语标准的使用与误用
BMC Cancer. 2016 Jul 4;16:392. doi: 10.1186/s12885-016-2408-9.